177 related articles for article (PubMed ID: 30905398)
1. The Discovery of a LEMD2-Associated Nuclear Envelopathy with Early Progeroid Appearance Suggests Advanced Applications for AI-Driven Facial Phenotyping.
Marbach F; Rustad CF; Riess A; Đukić D; Hsieh TC; Jobani I; Prescott T; Bevot A; Erger F; Houge G; Redfors M; Altmueller J; Stokowy T; Gilissen C; Kubisch C; Scarano E; Mazzanti L; Fiskerstrand T; Krawitz PM; Lessel D; Netzer C
Am J Hum Genet; 2019 Apr; 104(4):749-757. PubMed ID: 30905398
[TBL] [Abstract][Full Text] [Related]
2. Dermal fibroblasts in Hutchinson-Gilford progeria syndrome with the lamin A G608G mutation have dysmorphic nuclei and are hypersensitive to heat stress.
Paradisi M; McClintock D; Boguslavsky RL; Pedicelli C; Worman HJ; Djabali K
BMC Cell Biol; 2005 Jun; 6():27. PubMed ID: 15982412
[TBL] [Abstract][Full Text] [Related]
3. The third case of Marbach-Rustad progeroid syndrome caused by a de novo LEMD2 variant.
Lu Z; Zhang W; Mao X; Li D; Chen X; Liu L; Lin Y
Clin Genet; 2024 Feb; 105(2):209-213. PubMed ID: 37867468
[TBL] [Abstract][Full Text] [Related]
4. Exome sequencing reveals a de novo POLD1 mutation causing phenotypic variability in mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome (MDPL).
Elouej S; Beleza-Meireles A; Caswell R; Colclough K; Ellard S; Desvignes JP; Béroud C; Lévy N; Mohammed S; De Sandre-Giovannoli A
Metabolism; 2017 Jun; 71():213-225. PubMed ID: 28521875
[TBL] [Abstract][Full Text] [Related]
5. Blocking protein farnesyltransferase improves nuclear blebbing in mouse fibroblasts with a targeted Hutchinson-Gilford progeria syndrome mutation.
Yang SH; Bergo MO; Toth JI; Qiao X; Hu Y; Sandoval S; Meta M; Bendale P; Gelb MH; Young SG; Fong LG
Proc Natl Acad Sci U S A; 2005 Jul; 102(29):10291-6. PubMed ID: 16014412
[TBL] [Abstract][Full Text] [Related]
6. N6-isopentenyladenosine improves nuclear shape in fibroblasts from humans with progeroid syndromes by inhibiting the farnesylation of prelamin A.
Bifulco M; D'Alessandro A; Paladino S; Malfitano AM; Notarnicola M; Caruso MG; Laezza C
FEBS J; 2013 Dec; 280(23):6223-32. PubMed ID: 24112551
[TBL] [Abstract][Full Text] [Related]
7. SATB2-LEMD2 interaction links nuclear shape plasticity to regulation of cognition-related genes.
Feurle P; Abentung A; Cera I; Wahl N; Ablinger C; Bucher M; Stefan E; Sprenger S; Teis D; Fischer A; Laighneach A; Whitton L; Morris DW; Apostolova G; Dechant G
EMBO J; 2021 Feb; 40(3):e103701. PubMed ID: 33319920
[TBL] [Abstract][Full Text] [Related]
8. Loss of function of the nuclear envelope protein LEMD2 causes DNA damage-dependent cardiomyopathy.
Caravia XM; Ramirez-Martinez A; Gan P; Wang F; McAnally JR; Xu L; Bassel-Duby R; Liu N; Olson EN
J Clin Invest; 2022 Nov; 132(22):. PubMed ID: 36377660
[TBL] [Abstract][Full Text] [Related]
9. Analyses of LMNA-negative juvenile progeroid cases confirms biallelic POLR3A mutations in Wiedemann-Rautenstrauch-like syndrome and expands the phenotypic spectrum of PYCR1 mutations.
Lessel D; Ozel AB; Campbell SE; Saadi A; Arlt MF; McSweeney KM; Plaiasu V; Szakszon K; Szőllős A; Rusu C; Rojas AJ; Lopez-Valdez J; Thiele H; Nürnberg P; Nickerson DA; Bamshad MJ; Li JZ; Kubisch C; Glover TW; Gordon LB
Hum Genet; 2018 Dec; 137(11-12):921-939. PubMed ID: 30450527
[TBL] [Abstract][Full Text] [Related]
10. Imbalanced nucleocytoskeletal connections create common polarity defects in progeria and physiological aging.
Chang W; Wang Y; Luxton GWG; Östlund C; Worman HJ; Gundersen GG
Proc Natl Acad Sci U S A; 2019 Feb; 116(9):3578-3583. PubMed ID: 30808750
[TBL] [Abstract][Full Text] [Related]
11. Néstor-Guillermo progeria syndrome: a novel premature aging condition with early onset and chronic development caused by BANF1 mutations.
Cabanillas R; Cadiñanos J; Villameytide JA; Pérez M; Longo J; Richard JM; Alvarez R; Durán NS; Illán R; González DJ; López-Otín C
Am J Med Genet A; 2011 Nov; 155A(11):2617-25. PubMed ID: 21932319
[TBL] [Abstract][Full Text] [Related]
12. Nuclear envelope localization of LEMD2 is developmentally dynamic and lamin A/C dependent yet insufficient for heterochromatin tethering.
Thanisch K; Song C; Engelkamp D; Koch J; Wang A; Hallberg E; Foisner R; Leonhardt H; Stewart CL; Joffe B; Solovei I
Differentiation; 2017; 94():58-70. PubMed ID: 28056360
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic Insights of the LEMD2 p.L13R Mutation and Its Role in Cardiomyopathy.
Chen R; Buchmann S; Kroth A; Arias-Loza AP; Kohlhaas M; Wagner N; Grüner G; Nickel A; Cirnu A; Williams T; Maack C; Ergün S; Frantz S; Gerull B
Circ Res; 2023 Jan; 132(2):e43-e58. PubMed ID: 36656972
[TBL] [Abstract][Full Text] [Related]
14. Increased progerin expression associated with unusual LMNA mutations causes severe progeroid syndromes.
Moulson CL; Fong LG; Gardner JM; Farber EA; Go G; Passariello A; Grange DK; Young SG; Miner JH
Hum Mutat; 2007 Sep; 28(9):882-9. PubMed ID: 17469202
[TBL] [Abstract][Full Text] [Related]
15. Nesprin-2 giant safeguards nuclear envelope architecture in LMNA S143F progeria cells.
Kandert S; Lüke Y; Kleinhenz T; Neumann S; Lu W; Jaeger VM; Munck M; Wehnert M; Müller CR; Zhou Z; Noegel AA; Dabauvalle MC; Karakesisoglou I
Hum Mol Genet; 2007 Dec; 16(23):2944-59. PubMed ID: 17881656
[TBL] [Abstract][Full Text] [Related]
16. Compound heterozygosity for mutations in LMNA causes a progeria syndrome without prelamin A accumulation.
Verstraeten VL; Broers JL; van Steensel MA; Zinn-Justin S; Ramaekers FC; Steijlen PM; Kamps M; Kuijpers HJ; Merckx D; Smeets HJ; Hennekam RC; Marcelis CL; van den Wijngaard A
Hum Mol Genet; 2006 Aug; 15(16):2509-22. PubMed ID: 16825282
[TBL] [Abstract][Full Text] [Related]
17. Inhibiting farnesylation reverses the nuclear morphology defect in a HeLa cell model for Hutchinson-Gilford progeria syndrome.
Mallampalli MP; Huyer G; Bendale P; Gelb MH; Michaelis S
Proc Natl Acad Sci U S A; 2005 Oct; 102(40):14416-21. PubMed ID: 16186497
[TBL] [Abstract][Full Text] [Related]
18. A Novel Generalized Lipodystrophy-Associated Progeroid Syndrome Due to Recurrent Heterozygous LMNA p.T10I Mutation.
Hussain I; Patni N; Ueda M; Sorkina E; Valerio CM; Cochran E; Brown RJ; Peeden J; Tikhonovich Y; Tiulpakov A; Stender SRS; Klouda E; Tayeh MK; Innis JW; Meyer A; Lal P; Godoy-Matos AF; Teles MG; Adams-Huet B; Rader DJ; Hegele RA; Oral EA; Garg A
J Clin Endocrinol Metab; 2018 Mar; 103(3):1005-1014. PubMed ID: 29267953
[TBL] [Abstract][Full Text] [Related]
19. Hutchinson-Gilford progeria syndrome through the lens of transcription.
Prokocimer M; Barkan R; Gruenbaum Y
Aging Cell; 2013 Aug; 12(4):533-43. PubMed ID: 23496208
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic involvement in Hutchinson-Gilford progeria syndrome: a mini-review.
Arancio W; Pizzolanti G; Genovese SI; Pitrone M; Giordano C
Gerontology; 2014; 60(3):197-203. PubMed ID: 24603298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
